Less Ads, More Data, More Tools Register for FREE

RBC Capital starts Marlowe at 'outperform'

Wed, 13th Mar 2024 07:35

(Sharecast News) - RBC Capital Markets initiated coverage of Marlowe on Wednesday with an 'outperform' rating and 630p price target.

It noted that following the sale of its software & services assets on 22 February for £430m, Marlowe's stock rebounded by around 18%, reflecting "a slight reversal of investor sentiment".

However, the shares are still trading at a significant discount to peers.

"We believe the remaining underlying business is solid with annual organic growth of 5% and margins of 12-14% and efficiencies should drive further margin improvement by 1-2% by F2027E," RBC said.

"With the new CEO search underway, the short-term business strategy is intact. We expect the acquisition strategy will return longer term, but at a more moderate pace."


Shares in this article

Related News

Mitie hails annual sales growth, looks to grow data centre offering
16 Apr 2026

Mitie hails annual sales growth, looks to grow data centre offering

(Alliance News) - Mitie Group PLC on Thursday hailed sales growth in financial 2026, alongside announcing two acquisitions which it sees boosting its ...

Optima Health acquires PAM Healthcare in £100m deal
16 Feb 2026

Optima Health acquires PAM Healthcare in £100m deal

(Sharecast News) - Technology enabled health and wellbeing solutions provider Optima Health has agreed to acquire PAM Healthcare in a deal worth aroun...

CORRECT: Mitie shares rise as reports first-quarter revenue growth
22 Jul 2025

CORRECT: Mitie shares rise as reports first-quarter revenue growth

(Corrects description of Marlowe.)

Mitie + 1 more share